Ledger.Open graph →

SEC Form D · filed August 13, 2024

Convergent Therapeutics, Inc

Offering

$40.0M

Sold

$22.2M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

CAMBRIDGE, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Neil Bander · Cambridge, MAExec · Director Philip Kantoff · Cambridge, MAExec · Director Tal Zaks · Cambridge, MADirector Jake Simson · Cambridge, MADirector Alexander Brown · Cambridge, MAExec Jim Trenkle · Cambridge, MADirector Dan K. Thomason · Greenville, SCExec · Director Stacey-Ann Kirkconnell · GEORGE TOWN, GRAND CAYMAN, Cayman IslandsDirector Jonathan Hua Jun Xiong · SINGAPORE, U0Exec Vincent Palmieri · Larchmont, NYDirector Neil Mackie · EDINBURGH, United KingdomExec · Director Eric Sullivan · San Francisco, CAExec Brooke T. Lambert · New York, NYExec · Director Avi Cohen · Lod, L3Director Christine Y. Zhao · Lod, L3Exec · Director Todd Thomson · Lod, L3Exec Fang Zheng · Lod, L3Director Eric Sullivan · San Francisco, CAExec Jim Trenkle · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗